FCPI: Providing Diversification While Targeting A High-Inflation Environment #FCPI #Providing #Diversification #Targeting #HighInflation #Environment
Tag: Targeting
Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China’s First SSTR4 Agonist Targeting Pain By Investing.com
GUANGZHOU, China, Jan. 17, 2025 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical (TADAWUL:)…
Tenaya Therapeutics: TN-201 Isn't The Only Shot On Goal Targeting Heart Disease
Tenaya Therapeutics: TN-201 Isn't The Only Shot On Goal Targeting Heart Disease #Tenaya #Therapeutics #TN201 #Isn039t…
IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors
Exclusive global license outside of Greater China for SHR-4849, a Phase 1 DLL3-targeting Topo-I-payload antibody drug…
Okeanis Eco Tankers: Targeting Efficiency Gains, With The Youngest Fleet
For almost a decade, I held research analyst positions in various investment firms, mostly in Toronto.…
A More Robust Macro Risk Targeting Strategy for Equities
Investors who want to target exposure to macroeconomic risks in their equity investments can enhance the…
ADC Therapeutics: Continues To Make Strides With ZYNLONTA Targeting DLBCL (NYSE:ADCT)
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector…